SCHEMBL2496567

SCHEMBL2496567

COc1ccc(Cl)cc1C1(N2C[C@H](O)C[C@H]2C(=O)N(C)C)C(=O)Nc2ccc(Cl)c(C)c21

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 12/20 0.51
AVPR1A P37288 11/20 0.51
OXTR P30559 11/20 0.51
AVPR2 P30518 3/20 0.51
GPR65 Q8IYL9 1/20 0.51
BRD4 O60885 2/20 0.37
ACHE P22303 2/20 0.34
KCNQ3 O43525 1/20 0.33
KCNQ2 O43526 1/20 0.33
KCNQ4 P56696 1/20 0.33
KCNMA1 Q12791 1/20 0.33
KCNQ5 Q9NR82 1/20 0.33
MDM2 Q00987 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP8 P22894 1/20 0.33
MMP14 P50281 1/20 0.33
MMP17 Q9ULZ9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494463 0.91 AVPR1A (0.42) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2501951 0.90 AVPR1A (0.54) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2498127 0.88 AVPR1A (0.51) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2499475 0.88 AVPR1A (0.51) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2497748 0.88 AVPR1A (0.51) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2498927 0.88 AVPR1A (0.51) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2496640 0.87 AVPR1A (0.44) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2499523 0.86 AVPR1A (0.55) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2499794 0.86 AVPR1B (0.58) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2495124 0.86 AVPR1A (0.51) AVPR1BAVPR1AOXTRAVPR2GPR65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 AVPR1B 1/4885AVPR1A 2/4885OXTR 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.